Renting Rubin : AstraZeneca V – Follow The Science Out The Fucking Door
A former AstraZeneca vice-president alleges that she raised concerns about a manufacturing process, data presented to senior management and the
AstraZeneca
Renting Rubin : AstraZeneca III – The $400 Billion Adverse Reaction
The first AstraZeneca instalment examined its reputation-management placebo. Part II followed the company’s “patients first” rhetoric to the public purse.